This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (258)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Oncology  • Colon Cancer  • Quality of Care  • Evidence-Based Medicine  • Radiation Therapy  • Review  • Gastroenterology  • Gastrointestinal Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

A Meta-analysis

Calogero Cammà, MD; Marco Giunta, MD; Francesco Fiorica, MD; Luigi Pagliaro, MD; Antonio Craxì, MD; Mario Cottone, MD

JAMA. 2000;284:1008-1015.

Context  The benefit of adjuvant radiotherapy for resectable rectal cancer has been extensively studied, but data on survival are still equivocal despite a reduction in the rate of local recurrence.

Objective  To assess the effectiveness of preoperative radiotherapy followed by surgery in the reduction of overall and cancer-related mortality and in the prevention of local recurrence and distant metastases.

Data Sources  Computerized bibliographic searches of MEDLINE and CANCERLIT (1970 to December 1999), including non-English sources, were supplemented with hand searches of reference lists. The medical subject headings used were rectal cancer, radiotherapy, surgery, RCT, randomized, and clinical trial.

Study Selection  Studies were included if they were randomized controlled trials (RCTs) comparing preoperative radiotherapy plus surgery with surgery alone and if they included patients with resectable histologically proven rectal adenocarcinoma, without metastatic disease. Fourteen RCTs were analyzed.

Data Extraction  Data on population, intervention, and outcomes were extracted from each RCT according to the intention-to-treat method by 3 independent observers and combined using the DerSimonian and Laird method.

Data Synthesis  Radiotherapy plus surgery compared with surgery alone significantly reduced the 5-year overall mortality rate (odds ratio [OR] 0.84; 95% confidence interval [CI], 0.72-0.98; P = .03), cancer-related mortality rate (OR, 0.71; 95% CI, 0.61-0.82; P<.001), and local recurrence rate (OR, 0.49; 95% CI, 0.38-0.62; P<.001). No reduction was observed in the occurrence of distant metastases (OR, 0.93; 95% CI, 0.73-1.18; P = .54).

Conclusions  In patients with resectable rectal cancer, preoperative radiotherapy significantly improved overall and cancer-specific survival compared with surgery alone. The magnitude of the benefit is relatively small and criteria are needed to identify patients most likely to benefit from adjuvant radiotherapy.

Author Affiliations: Istituto Metodologie Diagnostiche Avanzate, Consiglio Nazionale delle Ricerche, Palermo, Italy (Dr Cammà); Cattedra di Gastroenterologia, Istituto di Clinica Medica (Drs Giunta, Fiorica, and Craxì), and Istituto di Medicina Generale e Pneumologia (Drs Pagliaro and Cottone), University of Palermo, Palermo, Italy.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLE

August 23, 2000
JAMA. 2000;284(8):1035-1036.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Molecular Response to Cetuximab and Efficacy of Preoperative Cetuximab-Based Chemoradiation in Rectal Cancer
Debucquoy et al.
JCO 2009;27:2751-2757.
ABSTRACT | FULL TEXT  

Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study
Carlomagno et al.
Ann Oncol 2009;20:906-912.
ABSTRACT | FULL TEXT  

Improvement of Survival With Response to Neoadjuvant Radiation Therapy for Rectal Cancer
Castaldo et al.
Arch Surg 2009;144:129-134.
ABSTRACT | FULL TEXT  

An Interval >7 Weeks between Neoadjuvant Therapy and Surgery Improves Pathologic Complete Response and Disease-Free Survival in Patients with Locally Advanced Rectal Cancer
Tulchinsky et al.
Ann. Surg. Oncol. 2008;15:2661-2667.
ABSTRACT | FULL TEXT  

Patient and Physician Preferences for Surgical and Adjuvant Treatment Options for Rectal Cancer
Harrison et al.
Arch Surg 2008;143:389-394.
ABSTRACT | FULL TEXT  

Radiation Therapy in Stage II and III Rectal Cancer
Willett et al.
Clin. Cancer Res. 2007;13:6903s-6908s.
ABSTRACT | FULL TEXT  

Multidisciplinary treatment of rectal cancer: medical oncology.
Aschele and Lonardi
Ann Oncol 2007;18:1908-1915.
FULL TEXT  

Locally Advanced Rectal Cancer: What Is the Evidence for Induction Chemoradiation?
Glynne-Jones and Harrison
The Oncologist 2007;12:1309-1318.
ABSTRACT | FULL TEXT  

Omission of concurrent chemoradiation after a response to neoadjuvant chemotherapy in locally advanced rectal cancer with a synchronous liver metastasis: a note of caution
Craven et al.
Br. J. Radiol. 2007;80:e257-e259.
ABSTRACT | FULL TEXT  

Analysis of Early Postoperative Morbidity Among Patients with Rectal Cancer Treated with and without Neoadjuvant Chemoradiotherapy
Valenti et al.
Ann. Surg. Oncol. 2007;14:1744-1751.
ABSTRACT | FULL TEXT  

Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer
Machiels et al.
Ann Oncol 2007;18:738-744.
ABSTRACT | FULL TEXT  

Colorectal Cancer
Gill et al.
Mayo Clin Proc. 2007;82:114-129.
ABSTRACT | FULL TEXT  

Surgical Adjuvant Therapy for Colorectal Cancer: Current Approaches and Future Directions
Monga and O'Connell
Ann. Surg. Oncol. 2006;13:1021-1034.
ABSTRACT | FULL TEXT  

Adjuvant Therapy in Rectal Cancer: What is the Truth?
Takiuchi
Jpn J Clin Oncol 2006;36:191-192.
FULL TEXT  

Quality of systematic reviews used in guidelines for oncology practice
Vigna-Taglianti et al.
Ann Oncol 2006;17:691-701.
ABSTRACT | FULL TEXT  

Can Rectal Cancers With Pathologic T0 After Neoadjuvant Chemoradiation (ypT0) Be Treated by Transanal Excision Alone?
Tulchinsky et al.
Ann. Surg. Oncol. 2006;13:347-352.
ABSTRACT | FULL TEXT  

Improved Staging With Pretreatment Positron Emission Tomography/Computed Tomography in Low Rectal Cancer
Gearhart et al.
Ann. Surg. Oncol. 2006;13:397-404.
ABSTRACT | FULL TEXT  

The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been?
Glynne-Jones et al.
Ann Oncol 2006;17:361-371.
ABSTRACT | FULL TEXT  

A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer
Glynne-Jones et al.
Ann Oncol 2006;17:50-56.
ABSTRACT | FULL TEXT  

Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study
Machiels et al.
Ann Oncol 2005;16:1898-1905.
ABSTRACT | FULL TEXT  

Swedish Rectal Cancer Trial: Long Lasting Benefits From Radiotherapy on Survival and Local Recurrence Rate
Folkesson et al.
JCO 2005;23:5644-5650.
ABSTRACT | FULL TEXT  

Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
Sauer et al.
NEJM 2004;351:1731-1740.
ABSTRACT | FULL TEXT  

Management of colorectal cancers
Lewis et al.
Qual Saf Health Care 2004;13:400-404.
ABSTRACT | FULL TEXT  

Patient Selection, Realism, and Randomized Clinical Trials
Tepper
JCO 2004;22:3215-3217.
FULL TEXT  

Preoperative MRI of Rectal Cancer With and Without Rectal Water Filling: An Intraindividual Comparison
Kim et al.
Am. J. Roentgenol. 2004;182:1469-1476.
ABSTRACT | FULL TEXT  

Impact of Preoperative Staging and Chemoradiation Versus Postoperative Chemoradiation on Outcome in Patients With Rectal Cancer: A Decision Analysis
Telford et al.
JNCI J Natl Cancer Inst 2004;96:191-201.
ABSTRACT | FULL TEXT  

Racial Disparities in Rectal Cancer Treatment: A Population-Based Analysis
Morris et al.
Arch Surg 2004;139:151-155.
ABSTRACT | FULL TEXT  

Cost-Utility Analysis of Preoperative Radiotherapy in Patients With Rectal Cancer Undergoing Total Mesorectal Excision: A Study of the Dutch Colorectal Cancer Group
van den Brink et al.
JCO 2004;22:244-253.
ABSTRACT | FULL TEXT  

Preoperative Chemoradiation for Rectal Cancer: A Different Perspective
Bozzetti
Ann. Surg. Oncol. 2002;9:1033-1034.
FULL TEXT  

Surgery for colorectal cancer
Dorudi et al.
Br Med Bull 2002;64:101-118.
ABSTRACT | FULL TEXT  

Radiotherapy in rectal cancer
Glimelius
Br Med Bull 2002;64:141-157.
ABSTRACT | FULL TEXT  

Adjuvant Therapy in Rectal Cancer: Analysis of Stage, Sex, and Local Control--Final Report of Intergroup 0114
Tepper et al.
JCO 2002;20:1744-1750.
ABSTRACT | FULL TEXT  

Randomized Trial of Postoperative Adjuvant Therapy in Stage II and III Rectal Cancer to Define the Optimal Sequence of Chemotherapy and Radiotherapy: A Preliminary Report
Lee et al.
JCO 2002;20:1751-1758.
ABSTRACT | FULL TEXT  

Effect of Preoperative Radiochemotherapy on Lymph Node Retrieval After Resection of Rectal Cancer
Wichmann et al.
Arch Surg 2002;137:206-210.
ABSTRACT | FULL TEXT  

Adjuvant Radiation Therapy of Rectal Cancer
Tepper
JCO 2001;19:3709-3711.
FULL TEXT  

Who Gets Adjuvant Treatment for Stage II and III Rectal Cancer? Insight From Surveillance, Epidemiology, and End Results-Medicare
Schrag et al.
JCO 2001;19:3712-3718.
ABSTRACT | FULL TEXT  

Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
Kapiteijn et al.
NEJM 2001;345:638-646.
ABSTRACT | FULL TEXT  

Improving Chemoradiotherapy in Rectal Cancer
Glynne-Jones and Debus
The Oncologist 2001;6:29-34.
ABSTRACT | FULL TEXT  

Preoperative Radiotherapy for Resectable Rectal Cancer: A Meta-Analysis
JWatch Gastroenterology 2000;2000:6-6.
FULL TEXT